Fetal MRI reference ranges for normal brain development
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study uses fetal MRI scans from a large group of healthy pregnancies to create standard growth charts for brain measurements. This helps doctors better understand normal fetal brain development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pregnant woman in the Born in Guangzhou Cohort Study
- Your fetus has no prenatal diagnosis of congenital heart disease or other congenital diseases
- Your baby is not expected to be born preterm, with extremely low birth weight, or small for gestational age
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to better predict fetal growth restriction (when a baby doesn't grow as expected) in women who have certain risk factors. By joining, you may help doctors develop better screening tools for future pregnancies.
This trial looks at how to diagnose and manage pregnancies and babies affected by slow growth before birth, birth defects, or chromosome-related conditions. It may help by improving how doctors confirm problems and plan care for mothers and newborns.
This study looks at past fetal MRI scans to create a map of normal brain growth in babies before birth. It may help doctors better understand what healthy brain development looks like.
This study uses a special type of MRI (magnetic resonance imaging) to look at the brain development of babies who are growing slowly in the womb. The goal is to see if this scan can help doctors better understand this condition and how to care for these babies.
This study looks at how a mother's health and experiences during pregnancy may affect her baby's brain growth and early development. You and your baby would have special MRI brain scans, fill out some questionnaires, and then your child's development would be followed until they are 6 years old.
This study collects blood samples and health information from healthy full-term newborns to establish normal ranges for brain-related markers in early life. Understanding these baseline levels may help doctors better identify babies who need extra care in the future.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.